Clinical Trial: Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759362) titled 'Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)' on Aug. 07.

Brief Summary: The primary purpose of this study is to assess the efficacy, safety, and tolerability of KN3835 compared to placebo in the treatment of flexible/semi-flexible HMT.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Flexible Hammertoe Semi-flexible Hammertoe

Intervention: BIOLOGICAL: KN3835

Participants will receive KN3835.

OTHER: Placebo

Participants will receive placebo matching to KN3835.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Endo USA Inc., a Keenova Therapeutics Company

Published by H...